Seong I. Seo
Seoul, 135710, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 234 publications
ASO Visual Abstract: Initial and Repeat Metastasis-Directed Therapy in Systemic Therapy-Naïve Oligometastatic Renal Cell Carcinoma: Oncologic Outcomes and Risk-Based Stratification.
Journal: Annals of surgical oncology
Published: August 11, 2026
Incidence, predictors, and prognostic impact of pathological T3a upstaging after robot-assisted partial nephrectomy for clinical T1-T2 renal cell carcinoma.
Journal: Journal of robotic surgery
Published: February 23, 2026
Initial and Repeat Metastasis-Directed Therapy in Systemic Therapy-Naïve Oligometastatic Renal Cell Carcinoma: Oncologic Outcomes and Risk-Based Stratification.
Journal: Annals of surgical oncology
Published: October 15, 2025
Enhancing Risk Stratification in Equivocal Prostate Magnetic Resonance Imaging Lesions: Clinical Utility of Prostate Health Index and Prostate Health Index Density in Prostate Imaging-Reporting and Data System 3.
Journal: The world journal of men's health
Published: May 16, 2025
Inhibition of PREX1 Reverses Enzalutamide Resistance in Castration-Resistant Prostate Cancer.
Journal: The world journal of men's health
Published: April 15, 2025
Distinct prognostic and molecular profiles of fat versus vein invasion in T3a renal cell carcinoma.
Journal: British journal of cancer
Published: February 03, 2025
Diagnostic value of prostate health index in patients with no index lesion on mpMRI or negative previous combined biopsy.
Journal: Investigative and clinical urology
Published: January 06, 2025
Tumor-specific but immunosuppressive CD39+CD8+ T cells exhibit double-faceted roles in clear cell renal cell carcinoma.
Journal: Cell reports. Medicine
Published: September 24, 2024
Paradoxical Effect of Myosteatosis on the Immune Checkpoint Inhibitor Response in Metastatic Renal Cell Carcinoma.
Journal: Journal of cachexia, sarcopenia and muscle
Published: September 02, 2024
Skin rash in metastatic hormone sensitive prostate cancer patients treated with apalutamide: a retrospective multicenter study in Korea.
Journal: Prostate international
Published: August 29, 2024
Last Updated: 09/26/2026